Related Experiment Videos

[Platelet collection by apheresis with reduced use of citrate: quantitative and qualitative evaluation of three

J Moh-Klaren1, N Berriot, C Lecrubier

  • 1Poste d'Hémobiologie-Transfusion de l'Hôtel-Dieu, Secteur d'Hémobiologie-Transfusion, Paris Centre.

Insights

Optimizing platelet collection protocols using the Cobe Spectra apheresis system enhances platelet yield and function. Protocol 2 offers improved efficiency and in vitro platelet function compared to the standard method, despite a higher white blood cell count.

Area of Science:

  • Transfusion Medicine
  • Hematology

Background:

  • Platelet apheresis is crucial for transfusion support.
  • Optimizing collection efficiency and platelet quality is an ongoing challenge.
  • Citrate concentration impacts apheresis procedures and outcomes.

Purpose of the Study:

  • To compare the efficiency and in vitro platelet function of different apheresis protocols.
  • To determine the optimal anticoagulant/whole blood ratio for Cobe Spectra apheresis.
  • To evaluate the trade-offs between platelet yield, function, and leukocyte contamination.

Main Methods:

  • Comparison of three apheresis protocols on Cobe Spectra with varying citrate concentrations.
  • Determination of optimal anticoagulant/whole blood flow ratio to prevent clotting.
  • In vitro platelet function assessment using aggregometry.
  • Quantification of leukocyte contamination in collected platelet concentrates.

Main Results:

  • Protocol 2 demonstrated higher platelet collection efficiency (59%) than the standard protocol 1 (52%).
  • A less citrated environment (Protocol 2) preserved superior in vitro platelet function.
  • Protocol 3 showed higher efficiency but was rejected due to a 5% clotting risk.
  • Protocol 2 resulted in a higher number of platelet concentrates with >10(6) leukocytes.

Conclusions:

  • Protocol 2 represents an improved method for platelet apheresis on the Cobe Spectra.
  • Reduced citrate concentration enhances platelet collection efficiency and preserves in vitro platelet function.
  • Careful consideration of leukocyte contamination is necessary when implementing Protocol 2.

Related Concept Videos